Stockreport

Pharvaris Announces Orphan Designation Granted to Deucrictibant by the European Commission [Yahoo! Finance]

Pharvaris N.V. - Ordinary Shares  (PHVS) 
PDF B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to [Read more]